gemcitabine has been researched along with Carcinoma, Intraepithelial in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gellhaus, PT; Martin, AC; McElree, IM; Mott, SL; Nepple, KG; O'Donnell, MA; Packiam, VT; Richards, J; Steinberg, RL | 1 |
| Bizama, C; Buchegger, K; Espinoza, K; García, P; Ili, C; Leal, P; Obreque, J; Repetto, G; Roa, JC; Rosa, L; Suárez, F; Vergara-Gómez, L; Weber, H; Zhong, J | 1 |
| Hong, JY; Kim, ST; Lim, SH; Park, JO; Park, YS | 1 |
| Casadei, R; Chen, X; Chu, T; Dantes, Z; Di Marco, M; Friedman, RA; Habenicht, AJR; Hayakawa, Y; Ilmer, M; Iuga, AC; Jiang, Z; Kleespies, A; Macchini, M; Maurer, HC; Middelhoff, M; Mohanta, SK; Nagar, K; Neumann, J; Olive, KP; Reichert, M; Remotti, H; Renz, BW; Tailor, Y; Takahashi, R; Tanaka, T; Valenti, G; Wang, TC; Werner, J; Westphalen, CB; Worthley, DL | 1 |
| Balasubramanian, A; Davis, JW; Dinney, CP; Kamat, AM; Karam, JA; Matin, SF; Metcalfe, MJ; Navai, N; Papadopoulos, J; Wagenheim, G; Wood, CG; Xiao, L | 1 |
| Ahmadi, N; Amini, E; Bazargani, ST; Cai, J; Clifford, TG; Daneshmand, S; Djaladat, H; Hugen, CM; Miranda, G; Sherrod, AE | 1 |
| Bednar, F; Heidt, DG; Lee, CJ; Li, C; Proctor, E; Simeone, DM; Waghray, M; Yalamanchili, M | 1 |
| Lebret, T | 1 |
| Brausi, M; Fiorito, C; Gontero, P; Oderda, M; Pappagallo, G | 1 |
| Favaudon, V; Fernet, M; Huguet, F; Monnier, L; Touboul, E | 1 |
| Costello, E; Greenhalf, W; Neoptolemos, JP | 1 |
| Iba, A; Kohjimoto, Y; Shinka, T; Shintani, Y; Uekado, Y | 1 |
| Bassi, P; Crucitta, E; Dal Moro, F; De Marco, V; Longo, F; Marini, L; Pinto, F; Tavolini, IM; Zucchetti, M | 1 |
| Schmid, RM | 1 |
| Arends, J; Unger, C | 1 |
3 review(s) available for gemcitabine and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
[Nonmuscle-invasive bladder cancer (NMIBC): when to perform cystectomy?].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Cystectomy; Cystoscopy; Deoxycytidine; Disease Progression; Follow-Up Studies; Gemcitabine; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Prognosis; Risk Factors; Time Factors; Urinary Bladder Neoplasms | 2008 |
[New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis].
Topics: Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Cystadenoma, Mucinous; Delayed Diagnosis; Deoxycytidine; Disease Progression; Gemcitabine; Genes, Tumor Suppressor; Humans; Intercellular Signaling Peptides and Proteins; Mutation; Neoplasm Proteins; Oncogenes; Pancreatic Neoplasms; Precancerous Conditions; Radiation Tolerance; Signal Transduction | 2011 |
New biomarkers and targets in pancreatic cancer and their application to treatment.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; CD40 Antigens; Computational Biology; Deoxycytidine; Drug Therapy, Combination; Equilibrative Nucleoside Transport Proteins; Fluorouracil; Gemcitabine; Gene Rearrangement; Hedgehog Proteins; Humans; MicroRNAs; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Receptor Protein-Tyrosine Kinases; Signal Transduction; Treatment Outcome | 2012 |
3 trial(s) available for gemcitabine and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma in Situ; Cholangiocarcinoma; Erlotinib Hydrochloride; Gallbladder Neoplasms; Gemcitabine; Humans; Pemetrexed; Prospective Studies; Salvage Therapy | 2023 |
Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: what does an aborted trial tell us?
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ; Cystitis; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Leukopenia; Male; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2013 |
Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guérin therapy.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antimetabolites, Antineoplastic; BCG Vaccine; Biopsy; Carcinoma in Situ; Chromatography, High Pressure Liquid; Cystoscopy; Deoxycytidine; Disease-Free Survival; Drug Resistance; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Ribonucleotide Reductases; Treatment Outcome; Urinary Bladder Neoplasms | 2005 |
9 other study(ies) available for gemcitabine and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Bacillus; BCG Vaccine; Carcinoma in Situ; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms | 2022 |
A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance.
Topics: Carcinoma in Situ; Cell Line, Tumor; Deoxycytidine; Gallbladder Neoplasms; Gemcitabine; Humans; Proteomics | 2023 |
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.
Topics: Adrenergic Agents; Animals; Carcinoma in Situ; Catecholamines; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Mice, Transgenic; Nerve Growth Factors; Pancreatic Neoplasms | 2018 |
Salvage topical therapy for upper tract urothelial carcinoma.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Mitomycin; Nephrostomy, Percutaneous; Retrospective Studies; Salvage Therapy; Treatment Outcome; Ureteral Neoplasms; Urinary Catheterization | 2018 |
Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 2019 |
Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Apoptosis; Carcinoma in Situ; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Silencing; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplastic Stem Cells; Pancreatic Neoplasms; Phenotype; Polycomb Repressive Complex 1; Xenograft Model Antitumor Assays | 2013 |
[Treatment of Bacillus Calmette-Guerin refractory superficial bladder cancer: further intravesical therapy].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Salvage Therapy; Urinary Bladder Neoplasms | 2005 |
[Pancreatic cancer].
Topics: Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cyclin-Dependent Kinase Inhibitor p16; Deoxycytidine; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Palliative Care; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Smad4 Protein; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2006 |
Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms | 2001 |